...in the news

Displaying 91 - 100 of 279 (10 per page)

Score	HS	BSN	CLB	EQT	IPO	M&A	IP	Date
								Jul 30, 2013
MRIGlobal, Evogen Announce Agreement in Development of Diagnostic Solutions
								Nov 12, 2015
Eiger BioPharmaceuticals Announces Acquisition of Exclusive License to Program for Treatment of Post-Bariatric Hypoglycemia from Stanford University: Clinical Proof of Concept Data Already Generated in Patients
								Aug 24, 2015
Medivation to Expand Global Oncology Franchise with the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, from BioMarin
								Feb 23, 2011
Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh: Drug Candidate Expands Company's Pipeline of Oncology Compounds Directed to Targets on Cancer Stem Cells and Tumor Bulk
								Nov 23, 2010
Omeros Announces Completion of Acquisition of Assay for GPCR Program
								Apr 4, 2011
OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
								Aug 10, 2015
AstraZeneca's (AZN) MedImmune to Acquire Inovio Pharma's (INO) NO-3112 Immunotherapy Rights
								Mar 31, 2015
RedHill Biopharma Acquires Phase II First-in-Class Oral Small Molecule SK2 Inhibitor from Apogee Biotech
								Apr 4, 2013
Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquinâ¢
								Apr 6, 2015
Regulatory Agencies in Asia and the U.S. Purchase Multiple Licenses of Simulations Plus Software